News | February 10, 2011

Hospital Study Demonstrates CT System’s Cost Savings With Stroke


February 10, 2011 – A study at Millard Fillmore Circle Gates Hospital in Buffalo, N.Y., found that Toshiba imaging equipment presented significant benefits, both for the patients and hospital.

To quantify the results of utilizing the Aquilion ONE for acute stroke, the hospital conducted a non-controlled study to measure the impact of 320-detector row dynamic volume CT. It evaluated data from before and after the system’s installation and addressed the top three discharging ICD-9-CM codes.

Prior to installing the system, most patients were imaged using pre-MRI screening and X-ray imaging, limited brain MRI, MR perfusion and MRA of the head and neck. Utilizing the Aquilion ONE showed a significant shift in the diagnostic workup for acute stroke. The expanded use of CT during stroke diagnosis resulted in reduced healthcare costs and improved patient outcomes, as MR is more user-intensive and costly. Furthermore, the images produced by CT allowed patients to be moved more quickly into intervention.

“With stroke accounting for 1 in every 18 deaths in the U.S. and costing the healthcare system approximately $50 billion a year, advanced imaging technologies are allowing us to diagnose stroke more accurately and efficiently than ever before,” said Elad Levy, M.D., FACS, FAHA, professor of Neurosurgery, University at Buffalo Neurosurgery, and director of endovascular stroke service for the Gates Stroke Center. “The whole brain perfusion and digital angiography capabilities of the Aquilion ONE provide our clinicians with the information needed to evaluate the penumbra or the region impacted by the stroke, quickly and accurately.”

On average, patients who were scanned on the system had their hospital stay reduced by nearly half a day. Additionally, for just the three ICD-9-CM codes studied, Millard Fillmore achieved an estimated annualized savings of more than $750,000 by utilizing the system to diagnose acute stroke.

For more information: www.medical.toshiba.com


Related Content

News | Cardiovascular Clinical Studies

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

Home May 18, 2024
Home
News | Cardiovascular Clinical Studies

May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results ...

Home May 17, 2024
Home
News | Cardiovascular Clinical Studies

May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the ...

Home May 15, 2024
Home
News | Cardiovascular Clinical Studies

May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the ...

Home May 14, 2024
Home
News | Cardiovascular Clinical Studies

May 14, 2024 — An ambitious, nationwide clinical trial led by UVA Health’s Karen Johnston, MD, has provided doctors with ...

Home May 14, 2024
Home
News | Cardiovascular Clinical Studies

May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms ...

Home May 13, 2024
Home
News | Cardiovascular Clinical Studies

May 13, 2024 — Even though mortality and hospitalization rates have improved, the quality of life for those living with ...

Home May 13, 2024
Home
News | Cardiovascular Clinical Studies

May 10, 2024 — Scientists from Immanuel Kant Baltic Federal University proved that Raman spectroscopy, a method by which ...

Home May 10, 2024
Home
Subscribe Now